Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise…

The quest to understand Parkinson’s disease (PD), a neurodegenerative disorder characterized by motor dysfunction and a range of non-motor symptoms,…

In a groundbreaking study conducted by a team of researchers in Finland, a pressing concern has been illuminated—the unmet healthcare…

The intricate world of cardiac epigenetics emerges as a pivotal frontier in understanding heart diseases that plague millions globally. Heart…

In a groundbreaking development that challenges prevailing paradigms of cancer immunotherapy resistance, researchers have unveiled a novel intrinsic mechanism by…

In the rapidly evolving domain of decision-making, where uncertainty and complexity are intertwined, a groundbreaking study by researcher I. Alshammari…

Cohesin, a pivotal player in the realm of genome organization, has garnered much attention due to its multifaceted roles in…

Paediatric kidney tumours represent a fascinating yet complex area in the realm of childhood oncology. The landscape of these tumours…

Ultragenyx Pharmaceutical has reported the failure of a pair of late-phase brittle bone disease trials, prompting the biotech to prepare to…

Biohaven didn't receive the clinical readout it was hoping for over the festive period. As the biopharma wound down for…